Simultaneous subcutaneous implantable cardioverter-defibrillator and leadless pacemaker implantation for patients at high risk of infection: a retrospective case series report.
Calvagna GM, Valsecchi S.
J Interv Card Electrophysiol. 2023 Nov 8. doi: 10.1007/s10840-023-01684-9. Online ahead of print.
PMID:37938506
The effect of hyperkalaemia on cardiac rhythm devices.
Barold SS, Herweg B.
Europace. 2014 Apr;16(4):467-76. doi: 10.1093/europace/eut383. Epub 2014 Jan 23.
PMID:24465006
Sinus rhythm R-wave amplitude as a predictor of ventricular fibrillation undersensing in patients with implantable cardioverter-defibrillator.
Ruetz LL, Koehler JL, Brown ML, Jackson TE, Belk P, Swerdlow CD.
Heart Rhythm. 2015 Dec;12(12):2411-8. doi: 10.1016/j.hrthm.2015.08.012. Epub 2015 Aug 10.
PMID:26272520
Pre-discharge defibrillation testing: Is it still justified?
Kempa M, Królak T, Drelich Ł, Budrejko S, Daniłowicz-Szymanowicz L, Lewicka E, Kozłowski D, Raczak G.
Cardiol J. 2016;23(5):532-538. doi: 10.5603/CJ.a2016.0045. Epub 2016 Jul 7.